| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J Hartikka, M Staufenbiel, H Lübber. Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degeneration. Journal of neuroscience research. vol 32. issue 2. 1992-11-03. PMID:1357186. |
further analysis revealed that exposure of mesencephalic cultures to dibutyryl camp (dbcamp) during the first 3 days after plating increased the survival of dopaminergic neurons, whereas prolonged treatment attenuated the development of the dopamine uptake system. |
1992-11-03 |
2023-08-11 |
rat |
| S D Critz, R E Mar. Glutamate antagonists that block hyperpolarizing bipolar cells increase the release of dopamine from turtle retina. Visual neuroscience. vol 9. issue 3-4. 1992-11-02. PMID:1327088. |
the release of dopamine produced by pda was blocked by exogenous gaba and muscimol, suggesting that the pda-mediated release process was polysynaptic and involved a gabaergic synapse interposed between the bipolar and dopaminergic amacrine cells. |
1992-11-02 |
2023-08-11 |
Not clear |
| S D Critz, R E Mar. Glutamate antagonists that block hyperpolarizing bipolar cells increase the release of dopamine from turtle retina. Visual neuroscience. vol 9. issue 3-4. 1992-11-02. PMID:1327088. |
these results suggest that the primary neuronal chain mediating dopamine release in the turtle retina is: cone----hyperpolarizing bipolar cell----gabaergic amacrine cell----dopaminergic amacrine cell. |
1992-11-02 |
2023-08-11 |
Not clear |
| H J Wagner, I Wull. Contacts of dopaminergic interplexiform cells in the outer retina of the blue acara. Visual neuroscience. vol 9. issue 3-4. 1992-11-02. PMID:1390390. |
the dopaminergic pathway terminating on horizontal cells and photoreceptors is discussed with respect to the localization of dopamine receptors in the outer retina, and the control of adaptive changes such as retinomotor movements, spinule formation, and horizontal cell coupling. |
1992-11-02 |
2023-08-11 |
Not clear |
| S Pöğün, L Kanit, B E Oku. Learning-induced changes in D2 receptors of rat brain are sexually dimorphic. Pharmacology, biochemistry, and behavior. vol 43. issue 1. 1992-11-02. PMID:1409820. |
pharmacological agents known to stimulate monoamine systems improve memory, and destruction of the dopaminergic systems or dopamine depletion lead to impairments in various learning-related tasks. |
1992-11-02 |
2023-08-11 |
rat |
| J Z Nowak, A Kazula, K Gołembiowsk. Melatonin increases serotonin N-acetyltransferase activity and decreases dopamine synthesis in light-exposed chick retina: in vivo evidence supporting melatonin-dopamine interaction in retina. Journal of neurochemistry. vol 59. issue 4. 1992-10-26. PMID:1402901. |
the results obtained (1) indicate that melatonin in vivo potently inhibits dopamine synthesis selectively in retina, and (2) suggest that the increase in retinal nat activity evoked by melatonin in light-exposed chicks is an indirect action of the compound, and results from the disinhibition of the nat induction process from the dopaminergic (inhibitory) signal. |
1992-10-26 |
2023-08-11 |
chicken |
| A Ikegami, A Ozaki, H Hara, T Sukamoto, A Yamashita, K It. Neurochemical investigation on the effects of a new diphenylpiperazine calcium antagonist, KB-2796, on the central dopaminergic system of rats. Japanese journal of pharmacology. vol 58. issue 4. 1992-10-26. PMID:1405037. |
the effects of kb-2796, a new diphenylpiperazine calcium antagonist, on the striatal dopaminergic system of rats were investigated in comparison with various calcium antagonists and the dopamine antagonist chlorpromazine. |
1992-10-26 |
2023-08-11 |
rat |
| A Ikegami, A Ozaki, H Hara, T Sukamoto, A Yamashita, K It. Neurochemical investigation on the effects of a new diphenylpiperazine calcium antagonist, KB-2796, on the central dopaminergic system of rats. Japanese journal of pharmacology. vol 58. issue 4. 1992-10-26. PMID:1405037. |
these results indicate that flunarizine may affect dopaminergic neurotransmission by partially blocking dopamine d2 receptors, while kb-2796 has negligible in vivo effect on the dopaminergic system. |
1992-10-26 |
2023-08-11 |
rat |
| P S Goldman-Rakic, M S Lidow, J F Smiley, M S William. The anatomy of dopamine in monkey and human prefrontal cortex. Journal of neural transmission. Supplementum. vol 36. 1992-10-22. PMID:1527516. |
this chapter reviews recent evidence establishing the comparable organization of dopamine afferents and dopaminergic receptors in the human and monkey prefrontal cortex. |
1992-10-22 |
2023-08-11 |
human |
| J Manzanares, T W Toney, Y Tian, M J Eaton, K E Moore, K J Lookinglan. Sexual differences in the activity of periventricular-hypophysial dopaminergic neurons in rats. Life sciences. vol 51. issue 13. 1992-10-09. PMID:1522758. |
the activities of periventricular-hypophysial dopaminergic (da) neurons were compared in male and female rats by measuring dopamine synthesis (accumulation of 3,4-dihydroxyphenylalanine [dopa] after inhibition of l-aromatic amino acid decarboxylase) and metabolism (concentrations of 3,4-dihydroxyphenylacetic acid [dopac]) in terminals of these neurons in the intermediate lobe of the pituitary. |
1992-10-09 |
2023-08-11 |
rat |
| S Winberg, G E Nilsso. Induction of social dominance by L-dopa treatment in Arctic charr. Neuroreport. vol 3. issue 3. 1992-10-02. PMID:1515576. |
l-dopa was found to cause a dose-dependent increase in the brain levels of dopamine and 3,4-dihydroxyphenylacetic acid (dopac, a major dopamine metabolite), as well as an increase in the dopac/dopamine ratio (an index of dopaminergic activity). |
1992-10-02 |
2023-08-11 |
Not clear |
| W Asakura, K Matsumoto, H Ohta, H Watanab. REM sleep deprivation decreases apomorphine-induced stimulation of locomotor activity but not stereotyped behavior in mice. General pharmacology. vol 23. issue 3. 1992-09-30. PMID:1511844. |
effects of rapid eye movement (rem) sleep deprivation on central dopaminergic system were investigated by testing the behavioral responses to apomorphine and brain dopamine metabolism in mice. |
1992-09-30 |
2023-08-11 |
mouse |
| N B Mercuri, P Calabresi, G Bernard. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. Life sciences. vol 51. issue 10. 1992-09-29. PMID:1355254. |
the electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. |
1992-09-29 |
2023-08-11 |
Not clear |
| N B Mercuri, P Calabresi, G Bernard. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. Life sciences. vol 51. issue 10. 1992-09-29. PMID:1355254. |
electrophysiological experiments which study the activity of single dopaminergic neurons in the ventral mesencephalon have shown that dopamine and dopaminergic drugs reduce the firing frequency of these cells. |
1992-09-29 |
2023-08-11 |
Not clear |
| N B Mercuri, P Calabresi, G Bernard. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. Life sciences. vol 51. issue 10. 1992-09-29. PMID:1355254. |
in addition, substances which increase the release (amphetamine), the synthesis (levodopa) or block the uptake (cocaine, nomifensine, amineptine) of dopamine in the brain inhibit the firing activity of the dopaminergic cells throughout dopamine-mediated mechanisms. |
1992-09-29 |
2023-08-11 |
Not clear |
| N B Mercuri, P Calabresi, G Bernard. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. Life sciences. vol 51. issue 10. 1992-09-29. PMID:1355254. |
in this review, we will briefly examine the literature concerning the physiological and behavioural responses caused by dopamine and dopaminergic agents on the dopaminergic neurons of the ventral mesencephalon. |
1992-09-29 |
2023-08-11 |
Not clear |
| N B Mercuri, P Calabresi, G Bernard. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. Life sciences. vol 51. issue 10. 1992-09-29. PMID:1355254. |
our conclusion suggests that the electrophysiological actions of dopamine and dopamine-related drugs on dopaminergic cells in the ventral mesencephalon might be indicative of the pharmacological effects of these agents on the brain. |
1992-09-29 |
2023-08-11 |
Not clear |
| W D Le, J R Bostwick, S H Appe. Use of [3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing rat striatum. Brain research. Developmental brain research. vol 67. issue 2. 1992-09-25. PMID:1511527. |
in this study we determined the temporal association between the appearance of the dopamine transporter, measured by 1-[2-(diphenyl-methoxy)ethyl]-4-(3- phenylpropyl)-piperazine ([3h]-gbr12935), a potent and selective inhibitor of dopamine uptake, and other biochemical markers of dopaminergic nerve terminal growth into the developing striatum. |
1992-09-25 |
2023-08-11 |
rat |
| W D Le, J R Bostwick, S H Appe. Use of [3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing rat striatum. Brain research. Developmental brain research. vol 67. issue 2. 1992-09-25. PMID:1511527. |
these results indicate that the appearance of a structural, but not optimally functional, dopamine transporter may be the earliest detectable biochemical index of dopaminergic nerve terminal growth into the striatum during development. |
1992-09-25 |
2023-08-11 |
rat |
| M F Olson, B P Schimme. Heterologous desensitization of the human dopamine D1 receptor in Y1 adrenal cells and in a desensitization-resistant Y1 mutant. Molecular endocrinology (Baltimore, Md.). vol 6. issue 7. 1992-09-24. PMID:1354841. |
in the present study, parental y1 cells (y1ds) and the y1dr mutant were transfected with the gene encoding the human dopamine d1 receptor and examined for regulation of adenylyl cyclase by dopaminergic agonists. |
1992-09-24 |
2023-08-11 |
human |